BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18951949)

  • 1. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.
    Sheng S; Barnett DH; Katzenellenbogen BS
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):1-9. PubMed ID: 18951949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
    Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
    Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.
    Levy N; Tatomer D; Herber CB; Zhao X; Tang H; Sargeant T; Ball LJ; Summers J; Speed TP; Leitman DC
    Mol Endocrinol; 2008 Feb; 22(2):287-303. PubMed ID: 17962382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential utilization of nuclear and extranuclear receptor signaling pathways in the actions of estrogens, SERMs, and a tissue-selective estrogen complex (TSEC).
    Madak-Erdogan Z; Gong P; Katzenellenbogen BS
    J Steroid Biochem Mol Biol; 2016 Apr; 158():198-206. PubMed ID: 26689478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and functional characterization of PELP1/MNAR promoter.
    Mishra SK; Balasenthil S; Nguyen D; Vadlamudi RK
    Gene; 2004 Apr; 330():115-22. PubMed ID: 15087130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
    Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KISS1 is down-regulated by 17beta-estradiol in MDA-MB-231 cells through a nonclassical mechanism and loss of ribonucleic acid polymerase II binding at the proximal promoter.
    Huijbregts L; de Roux N
    Endocrinology; 2010 Aug; 151(8):3764-72. PubMed ID: 20534720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
    Barnett DH; Sheng S; Charn TH; Waheed A; Sly WS; Lin CY; Liu ET; Katzenellenbogen BS
    Cancer Res; 2008 May; 68(9):3505-15. PubMed ID: 18451179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
    Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
    J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus.
    Scafonas A; Reszka AA; Kimmel DB; Hou XS; Su Q; Birzin ET; Kim S; Chen HY; Tan Q; Roher SP; Dininno F; Hammond ML; Rodan GA; Towler DA; Schmidt A
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):197-206. PubMed ID: 18508261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics.
    Cirillo F; Nassa G; Tarallo R; Stellato C; De Filippo MR; Ambrosino C; Baumann M; Nyman TA; Weisz A
    J Proteome Res; 2013 Jan; 12(1):421-31. PubMed ID: 23170835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells.
    Bryant W; Snowhite AE; Rice LW; Shupnik MA
    Endocrinology; 2005 Feb; 146(2):751-9. PubMed ID: 15528307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
    Levenson AS; Svoboda KM; Pease KM; Kaiser SA; Chen B; Simons LA; Jovanovic BD; Dyck PA; Jordan VC
    Cancer Res; 2002 Aug; 62(15):4419-26. PubMed ID: 12154049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants for the tissue specificity of SERMs.
    Shang Y; Brown M
    Science; 2002 Mar; 295(5564):2465-8. PubMed ID: 11923541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of prothymosin alpha gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs.
    Martini PG; Katzenellenbogen BS
    Endocrinology; 2001 Aug; 142(8):3493-501. PubMed ID: 11459795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.